Startseite>>Peptides>>[Des-Arg9]-Bradykinin acetate

[Des-Arg9]-Bradykinin acetate

Katalog-Nr.GC33850

[Des-Arg9]-Bradykininacetat ist ein Bradykinin-B1-Rezeptoragonist, der SelektivitÄt fÜr B1- gegenÜber B2-Rezeptoren zeigt.

Products are for research use only. Not for human use. We do not sell to patients.

[Des-Arg9]-Bradykinin acetate Chemische Struktur

Cas No.: 23827-91-0

Größe Preis Lagerbestand Menge
5mg
50,00 $
Auf Lager
10mM (in 1mL Water)
85,00 $
Auf Lager
25mg
175,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

[Des-Arg9]-Bradykinin acetate is a Bradykinin B1 receptor agonist that displays selectivity for B1 over B2 receptors.

[Des-Arg9]-Bradykinin acetate is a Bradykinin(B1) receptor agonist. The B2 receptor mediates the action of bradykinin (BK) and lysyl-bradykinin (Lys-BK), the first set of bioactive kinins formed in response to injury from kininogen precursors through the actions of plasma and tissue kallikreins, whereas the B1 receptor mediates the action of [Des-Arg9]-Bradykinin (des-Arg9-BK) and Lys-des-Arg Arg9-BK, the second set of bioactive kinins formed through the actions of carboxypeptidases on BK and Lys-BK, respectively[1].

[1]. Leeb-Lundberg LM, et al. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev. 2005 Mar;57(1):27-77.

Bewertungen

Review for [Des-Arg9]-Bradykinin acetate

Average Rating: 5 ★★★★★ (Based on Reviews and 15 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for [Des-Arg9]-Bradykinin acetate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.